Keratin 17 (KRT17) Peptid
KRT17
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN939286
Kurzübersicht für Keratin 17 (KRT17) Peptid (ABIN939286)
Target
KRT17
(Keratin 17 (KRT17))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- IATYRRLLEG EDAHLTQYKK EPVTTRQVRT IVEEVQDGKV ISSREQVHQT
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KRT17 antibody,
Alternative Names: Cytokeratin 17 control peptide, Cytokeratin 17 antibody Blocking Peptide, Anti-Cytokeratin 17 Blocking Peptide, Keratin 17 Blocking Peptide, K17 Blocking Peptide, PC Blocking Peptide, PC2 Blocking Peptide, PCHC1 Blocking Peptide, KRT17 Blocking Peptide, Cytokeratin 17, Cytokeratin -17, Cytokeratin 17, Cytokeratin -17 Blocking Peptide, Cytokeratin 17 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- KRT17 (Keratin 17 (KRT17))
-
Hintergrund
- KRT17 is type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in its gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.KRT17 encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.
-
Molekulargewicht
- 48 kDa
Target
-
Sie sind hier:
